C
Claes Lassvik
Researcher at Linköping University
Publications - 18
Citations - 607
Claes Lassvik is an academic researcher from Linköping University. The author has contributed to research in topics: Middle cerebral artery & Probucol. The author has an hindex of 9, co-authored 18 publications receiving 602 citations.
Papers
More filters
Journal ArticleDOI
The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)
Göran Walldius,Uno Erikson,Anders G. Olsson,Lott Bergstrand,Karin Hådell,Jan Johansson,Lennart Kaijser,Claes Lassvik,Jörgen Mölgaard,Sven Nilsson,Liselotte Schäfer-Elinder,Göran Stenport,Ingar Holme +12 more
TL;DR: The Probucol Quantitative Regression Swedish Trial tested whether treatment of hypercholesterolemic persons with probucol for 3 years affected femoral atherosclerosis and found no difference between the treatment groups with regard to change in arterial edge roughness or amount of aorto-femoral Atherosclerosis.
Journal ArticleDOI
Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication.
TL;DR: The results suggest that folic acid supplementation should be tried in IC subjects with hyperhomocyst(e)inaemia, as it was independent of the other above‐mentioned risk factors.
Journal ArticleDOI
Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication.
Jörgen Mölgaard,I. C. Klausen,Claes Lassvik,Ole Faergeman,Lars Ulrik Gerdes,Anders G. Olsson +5 more
TL;DR: Stepwise logistic regression analysis demonstrated that Lp(a) concentration contributed significantly to intermittent claudication, independent of age, smoking, hypertension, diabetes mellitus, plasma total cholesterol, lowdensity lipoprotein cholesterol, high density lipop protein cholesterol, apo B, and plasma total triglycerides.
Journal ArticleDOI
Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status report
Göran Walldius,Lars A. Carlson,Uno Erikson,Anders G. Olsson,Jan Johansson,Jörgen Mölgaard,Sven Nilsson,Göran Stenport,Lennart Kaijser,Claes Lassvik,Ingar Holme +10 more
TL;DR: The Probucol Quantitative Regression Swedish Trial is being performed to investigate the effects of probucol on atherosclerosis in the femoral artery and some results from the open prerandomization phase of the study are presented.
Journal ArticleDOI
Restenosis and occlusion after carotid surgery assessed by duplex scanning and digital subtraction angiography.
Vera Zbornikova,Johan Elfstrom,Claes Lassvik,Ingegerd Johansson,Jan-Edvin Olsson,Ul F Bjornlert +5 more
TL;DR: V vessel morphology was examined with duplex scanning and digital subtraction angiography and an increased risk of atherosclerotic progression on the non-operated side in smokers and those with two or more risk factors was revealed.